Tradjenta and Thrombocytopenia aggravated - a phase IV clinical study of FDA data

Summary:

Thrombocytopenia aggravated is reported as a side effect among people who take Tradjenta (linagliptin), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Metformin, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Thrombocytopenia aggravated when taking Tradjenta. It is created by eHealthMe based on reports of 9,889 people who have side effects when taking Tradjenta from the FDA, and is updated regularly.

What is Tradjenta?

Tradjenta has active ingredients of linagliptin. It is often used in diabetes. eHealthMe is studying from 9,987 Tradjenta users. Check the latest studies of Tradjenta.

What is Thrombocytopenia aggravated?

Thrombocytopenia aggravated (decrease of platelets in blood) is found to be associated with 2,356 drugs and 873 conditions by eHealthMe. Check the latest studies of Thrombocytopenia aggravated.

On Jul, 07, 2026

9,889 people reported to have side effects when taking Tradjenta.
Among them, 74 people (0.75%) have Thrombocytopenia aggravated.

Could Tradjenta cause Thrombocytopenia aggravated?

Among these 74 people:

How long have people been on Tradjenta when they have Thrombocytopenia aggravated? *

What is the gender of people who have Thrombocytopenia aggravated when taking Tradjenta? *

female: 40 %
male: 60 %

What is the age of people who have Thrombocytopenia aggravated when taking Tradjenta? *

What are other drugs people take besides Tradjenta? *

What are other side effects people have besides Thrombocytopenia aggravated? *

Fatigue (feeling of tiredness): 19 people, 25.68%
White Blood Cell Count Decreased: 16 people, 21.62%
Haemoglobin Decreased: 13 people, 17.57%
Weakness: 12 people, 16.22%
Haematocrit Decreased: 11 people, 14.86%
Nausea (feeling of having an urge to vomit): 8 people, 10.81%
Pneumonia: 8 people, 10.81%
Rashes (redness): 8 people, 10.81%
Blood Creatinine Increased: 7 people, 9.46%
Neutrophil Count Decreased (less than normal number of neutrophil a type of blood cell): 6 people, 8.11%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 12 people, 16.22%
High Blood Pressure: 8 people, 10.81%
Pain: 4 people, 5.41%
Polycythaemia Vera (blood disorder in which the bone marrow makes too many red blood cells): 4 people, 5.41%
Nausea (feeling of having an urge to vomit): 4 people, 5.41%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 4 people, 5.41%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 4 people, 5.41%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 3 people, 4.05%
Burkitt Lymphoma (cancer of the lymphatic system): 3 people, 4.05%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 3 people, 4.05%

* Approximation only. Some reports may have incomplete information.

Do you take Tradjenta and have Thrombocytopenia aggravated?

- Check whether Thrombocytopenia aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tradjenta:

Tradjenta (9,987 reports)

Browse all side effects of Tradjenta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Thrombocytopenia aggravated:

Thrombocytopenia aggravated (2,356 drugs)

Browse all the conditions that are associated with Thrombocytopenia aggravated:

Thrombocytopenia aggravated (873 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on linagliptin (the active ingredients of Tradjenta) and Tradjenta (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.